Nutrition Business Journal
Why mushrooms cant win

Why mushrooms cant win

Consumer aversion, infighting & contradictory interpretations of science hold back a promising supplement category.

Used medicinally for millennia, you’d think mushrooms would be a super successful supplement category. Not so. According to NBJ research, U.S. consumer sales of mushroom supplements hit $29 million in 2011. That’s nothing to sneeze at, but the numbers fall far short of what they could—and many argue should—be. Study after study shows that mushroom supplements supply a bounty of bodily benefits, the most salient being immunity. Therefore, given real health sca

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

TAGS: Archive News
Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.